Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
145 studies found for:    "childhood myocerebrohepatopathy spectrum" OR "Mitochondrial Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
"childhood myocerebrohepatopathy spectrum" OR "Mitochondrial Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated Anesthetic Effects in Mitochondrial Disease
Condition: Mitochondrial Disease
Intervention: Drug: sevoflurane
2 Completed Glycemic Index in Mitochondrial Disease
Condition: Mitochondrial Diseases
Intervention: Other: test meal
3 Recruiting Anesthesia in Patients With Mitochondrial Disease
Condition: Mitochondrial Diseases
Interventions: Drug: Sevoflurane;   Drug: Dexmedetomidine;   Drug: Propofol
4 Recruiting Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease
Condition: Mitochondrial Disease
Intervention:
5 Completed
Has Results
Phase III Trial of Coenzyme Q10 in Mitochondrial Disease
Condition: Mitochondrial Diseases
Interventions: Drug: CoenzymeQ10;   Drug: Placebo
6 Not yet recruiting Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Disease (PMD)
Condition: Primary Mitochondrial Disease
Intervention: Drug: ELA4
7 Completed Survey on Supplement Use in Mitochondrial Disease
Condition: Mitochondrial Disease
Intervention:
8 Active, not recruiting Calf Muscle Strength in Mitochondrial Diseases
Condition: Mitochondrial Disease
Intervention: Other: MRI and muscle dynamometer
9 Enrolling by invitation A Long-Term Extension Study of RP103-MITO-001 to Assess RP103 in Children With Inherited Mitochondrial Disease
Condition: Mitochondrial Diseases
Intervention: Drug: Cysteamine Bitartrate Delayed-release Capsules
10 Recruiting The Effect of Arginine and Citrulline Supplementation on Endothelial Dysfunction in Mitochondrial Diseases
Condition: Mitochondrial Diseases
Interventions: Dietary Supplement: Arginine;   Dietary Supplement: Citrulline
11 Terminated RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease
Condition: Mitochondrial Diseases
Intervention: Drug: RG2133 (2',3',5'-tri-O-acetyluridine)
12 Enrolling by invitation A Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Injections of Elamipretide (MTP-131) in Subjects With Genetically Confirmed Mitochondrial Disease Previously Treated in the Stealth BioTherapeutics SPIMM-201 Study
Condition: Primary Mitochondrial Disease
Interventions: Drug: Elamipretide;   Drug: Placebo
13 Completed Energy Requirements in Mitochondrial Disease
Conditions: Mitochondrial Disease;   Chronic Metabolic Disorder
Intervention:
14 Enrolling by invitation DINAMITE Study Nutritional State and Effect Diet in Mitochondrial Disease
Condition: Mitochondrial Disorders
Intervention: Behavioral: diet intervention
15 Enrolling by invitation Open-Label, Dose-Escalating Study to Assess Safety, Tolerability, Efficacy, PK and PD of RP103 in Children With Inherited Mitochondrial Disease
Condition: Inherited Mitochondrial Disease, Including Leigh Syndrome
Intervention: Drug: Cysteamine Bitartrate Delayed-release Capsules (RP103)
16 Recruiting GDF-15 as a Biomarker for Mitochondrial Disease
Conditions: Mitochondrial Disease;   Metabolic Myopathy;   Muscular Dystrophy
Intervention:
17 Completed Gastrointestinal Dysfunction in Children Affected With Mitochondrial Disorders
Conditions: Gastrointestinal Dysfunction;   Mitochondrial Disorders
Intervention: Procedure: gastric emptying scan
18 Recruiting North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Conditions: Mitochondrial Disorders;   Mitochondrial Genetic Disorders;   Mitochondrial Diseases;   Disorder of Mitochondrial Respiratory Chain Complexes;   Deletion and Duplication of Mitochondrial DNA
Intervention:
19 Active, not recruiting EPI-743 for Mitochondrial Respiratory Chain Diseases
Condition: Mitochondrial Diseases
Intervention: Drug: EPI-743
20 Completed Economic and Medical Evaluation of the Whole Mitochondrial DNA Screening by Surveyor and Mitochips Techniques
Condition: Mitochondrial Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.